Page 4 - பல்கலைக்கழகம் ஆஃப் ஹைதராபாத் ஊஓ News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Anti-diabetic drug can be re-purposed as Covid treatment: Study   Sat, Jul 03 2021 10:09:13 AM Hyderabad, Jul 3 (IANS): Amid the rush to develop cures for the coronavirus, a study by a University of Hyderabad (UoH) incubated startup, has discovered that an anti-diabetic drug has potential use as a ready to use, cost-effective solution for safely treating Covid patients. In-vitro and in-silico studies conducted by ReaGene Innovations Private Limited, a startup company incubated at the ASPIRE-BioNEST, and INDRAS Private Limited, indicate that re-purposing the anti-diabetic drug Ertugliflozin, might provide a therapeutic solution to the Covid-19 infection. Ertugliflozin, an FDA-approved drug for type-2 diabetes, works as SGLT-2 inhibitor by removing excessive glucose through urine.

Andhra pradeshUday saxenaSubramanyam vangalaSreedhara voletiReagene innovations privateUniversity of hyderabad uoDepartment of biotechnologyReagene innovations private limitedReagene innovationsPatent cooperationஆந்திரா பிரதேஷ்ஊடாய் சகஷெணசுப்ரமணியம் வங்காளபல்கலைக்கழகம் ஆஃப் ஹைதராபாத் ஊஓதுறை ஆஃப் உயிரி தொழில்நுட்பவியல்காப்புரிமை ஒத்துழைப்பு